Woess K, Macho-Maschler S, van Ingen Schenau DS, Butler M, Lassnig C, Valcanover D, Poelzl A, Meissl K, Maurer B, Brandstoetter T, Vogl C, Koren A, Kubicek S, Orlova A, Moriggl R, Strobl B, Sexl V, van Leeuwen FN, Kuiper RP, Mueller M. Oncogenic TYK2 P760L kinase is effectively targeted by combinatorial TYK2, mTOR and CDK4/6 kinase blockade. haematol [Internet]. 2023Apr.1 [cited 2024Nov.28];108(4):993-1005. Available from: https://haematologica.org/article/view/haematol.2021.279848